Skip to main content
Premium Trial:

Request an Annual Quote

Lee McCracken

Molecular Diagnostics has appointed Lee McCracken to its board of directors. In 2014, McCracken was appointed CEO of Gensignia Life Sciences. Previously, he held positons as president and CEO of Pathwork Diagnostics. Before that, McCracken served as corporate head of business development at Prometheus Laboratories, senior vice president of pharma business development at Diversa (merged with Verenium), president and chief business officer of GenStar Therapeutics, and senior vice president of corporate development at CombiChem (acquired by DuPont Pharmaceuticals). 

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.